The 2026 Canadian Global Oncology Network (CGON) Conference

The 2026 Canadian Global Oncology Network (CGON) Conference

The 2026 Canadian Global Oncology Network (CGON) Conference brought together more than 170 researchers, clinicians, trainees, policymakers, and advocates from across Canada and around the world under the theme “Transforming Health Systems Through Global Oncology”. Co-hosted by the Princess Margaret Global Cancer Program and the University of Toronto Dalla Lana School of Public Health, the conference explored how investments in cancer control can strengthen health systems, advance equity, and improve outcomes for patients globally. 

Over two days, attendees engaged with 33 speakers across 11 sessions, featuring keynote presentations, multidisciplinary panels, research showcases, and networking opportunities. Discussions highlighted innovative approaches to health system strengthening, including the impact of AI, the importance of high-quality data, and how sharing lessons learned can advance cancer control both within Canada and abroad. The conference also provided a platform for early-career professionals to share their work and connect with leaders in the field.

As Canada’s leading national forum for global oncology, CGON continues to foster collaboration, mobilize knowledge, and connect stakeholders across Canada who are committed to advancing global cancer control.

Find out more and visit the CGON website at: https://www.canadianglobaloncology.ca/

SELAC 2026

SELAC 2026

SELAC 2026 will virtually convene global leaders, healthcare professionals, researchers, policymakers, patient advocates, and innovators from 13–17 April 2026. Hosted online at www.selac.org, the event continues its mission of advancing collaboration, innovation, and equitable cancer control across Latin America.

This year’s programme will bring together multidisciplinary voices to address key challenges in cancer prevention, treatment, and survivorship, while fostering partnerships that support improved access to care and stronger regional collaboration.

Why Participate?

Shape the future – Contribute to conversations helping define the future of cancer control across Latin America.

Engage in dynamic discussions – Explore advances in areas such as precision oncology, early detection, health equity, and emerging research shaping cancer care.

Share expertise – Present your experience through presentations and panel discussions alongside global experts.

Network globally – Connect with multidisciplinary professionals, researchers, policymakers, and patient advocates to spark collaborations that transcend borders.

Drive policy impact – Help inform actionable strategies aimed at improving cancer care access and outcomes in underserved communities.

Find out more and register at: https://www.selac.org

The Lancet – In Conversation with…

The Lancet – In Conversation with…

In this episode of The Lancet in conversation with, Dr Susannah Stanway reflects on the growing role of London Global Cancer Week in bringing the global oncology community together. Speaking with editors from The Lancet, she explores how collaboration across disciplines and countries can drive progress in cancer prevention, diagnosis, and treatment, while highlighting the importance of equity, evidence-based care, and coordinated global action in improving outcomes for patients worldwide.  

LGCW on eCancer

LGCW on eCancer


A series of London Global Cancer Week interviews featuring speakers and partners is now available on the ecancer network—watch the full collection here.

An overview of LGCW 2025

An overview of LGCW 2025

Dr Susannah Stanway gives an overview of the London Global Cancer Week 2025 meeting that she co-convened.

She begins by discussing how vital it is to bring all the partners and stakeholders together, such as: healthcare, government, faith leaders, economists, industry and patients with lived experience.

Dr Stanway covers some of the areas within international crises that sessions have focussed on including conflict, climate change, artificial intelligence and finances.